Available from: Marcinkowska A, Grnicka M
Aetnas typical PA requirements for Wegovy and Zepbound include: Documented BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea) Evidence of participation in a structured weight management program (diet, exercise, behavioral counseling) for a minimum period often 3 to 6 months Documentation that other weight loss interventions have been attempted Prescriber must be a physician, NP, or PA with appropriate prescribing authority Prior authorization is not a denial it is a documentation requirement
However, from a pricing and product management standpoint, insurers may also want to consider behavioral responses and contract dynamics
It enhances the activity of neurons, improves memory formation, and protects against cell lossa key factor in diseases related to aging and brain degeneration
Research reference compound supplied for laboratory research only